3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
11
Burkitt Lymphoma
8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Smoldering Multiple Myeloma
2
Lymphoma, Mantle-Cell
2
Lung Neoplasms
2
Immunoglobulin Light-chain Amyloidosis
2
Down Syndrome
2
Neoplasms
1
Neoplasm Metastasis
1
Leukemia, Plasma Cell
1
Leukemia, Biphenotypic, Acute
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Brain Neoplasms
1
Ann Arbor Stage II Mantle Cell Lymphoma
1
Interventions
Magnetic Resonance Spectroscopy
4
Specimen Handling
3
lutetium Lu 177 dotatate
2
Bevacizumab
2
regorafenib
1
olaparib
1
neratinib
1
gallium Ga 68 dotatate
1
capivasertib
1
cabozantinib
1
brigatinib
1
abemaciclib
1
Watchful Waiting
1
Tablets
1
Surveys and Questionnaires
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Protons
1
Proton Therapy
1
Observation
1
Nivolumab
1
Lysine
1
Ipilimumab
1
Hydroxyurea
1
HhAntag691
1
Ga(III)-DOTATOC
1
GSK2256098
1
Everolimus
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Meningioma
×
dexamethasone acetate
×
30 days
×
Clear all
No trials found.